Karolinska Development AB Signs Agreement With Mayo Clinic

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Karolinska Development AB (publ) (STO:KDEV) has entered into an agreement with Mayo Clinic with the aim of identifying commercialization opportunities in Mayo’s life science innovations that will improve patient care. Through this agreement, Karolinska Development will evaluate innovations from Mayo Clinic. The collaboration will increase the possibilities for life science investments in differentiated world-class scientific innovations. Investments in commercially-interesting innovations may then be made by both parties, jointly or independently. As a not-for-profit institution, revenue that Mayo receives from such investments is used to support Mayo’s education and research endeavors. Torbjörn Bjerke, CEO, Karolinska Development: "Karolinska Development invests in world-class innovations, currently from the best Nordic institutions. Mayo Clinic is one of the finest medical institutions; it is a globally-recognised powerhouse of patient treatment and life sciences innovation, similar to the Karolinska Institutet and other institutions with which Karolinska Development has co-operation agreements. Through this agreement, Karolinska Development will not only gain access to an additional continuous flow of new ideas and projects, but we will also be able to showcase our own innovations for an excellent investor in life science.”